• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Phathom Pharmaceuticals, Inc. - Common Stock (NQ:PHAT)

    8.785 -0.015 (-0.17%)
    Streaming Delayed Price Updated: 10:56 AM EDT, Aug 26, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 195,284
    Open 8.780
    Bid (Size) 8.770 (200)
    Ask (Size) 8.800 (100)
    Prev. Close 8.800
    Today's Range 8.571 - 8.841
    52wk Range 8.210 - 18.31
    Shares Outstanding 43,614,075
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    PHAT Investor Alert: Levi & Korsinsky Notifies Investors of Investigation Into Phathom Pharmaceuticals, Inc. (PHAT)
    From Levi & Korsinsky, LLP
    Via Business Wire
    News headline image
    Phathom Pharmaceuticals Q2 Earnings Call Highlights ↗
    Phathom Pharmaceuticals (NASDAQ:PHAT) reported second-quarter 2026 revenue growth of 88% year over year and said it achieved positive operating profit excluding stock-based compensation for the first... 
    Via MarketBeat
    Topics Earnings

    Performance

    YTD
    -44.1%
    -44.1%
    1 Month
    -26.5%
    -26.5%
    3 Month
    -20.9%
    -20.9%
    6 Month
    -24.3%
    -24.3%
    1 Year
    -24.1%
    -24.1%

    More News

    Read More
    Phathom Pharmaceuticals (PHAT) Falls After Cutting 2026 Revenue Guidance Despite Q2 Beat ↗
    Via Chartmill
    News headline image
    Phathom Pharmaceuticals Reports Second Quarter 2026 Financial Results and Provides Business Update
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    Phathom Pharmaceuticals (NASDAQ:PHAT) Smashes Q1 Expectations, Nears Profitability Milestone ↗
    Via Chartmill
    Phathom Pharmaceuticals (NASDAQ:PHAT) Q4 2025 Earnings: Revenue Beat and Narrowed Losses Signal Path to Profitability ↗
    Via Chartmill
    News headline image
    Phathom Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide Business Update on Thursday, July 30, 2026
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals Completes Patient Enrollment Ahead of Schedule in Phase 2 pHalcon-EoE-201 Study of VOQUEZNA® (vonoprazan) in Eosinophilic Esophagitis (EoE)
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals Highlights Breadth of Independent Vonoprazan Research at Digestive Disease Week 2026 Annual Meeting
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals to Highlight VOQUEZNA® (vonoprazan) at DDW 2026 Annual Meeting
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom (PHAT) Q1 2026 Earnings Transcript ↗
    Via The Motley Fool
    News headline image
    Phathom Pharmaceuticals Reports First Quarter 2026 Financial Results and Provides Business Update
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals to Report First Quarter 2026 Financial Results and Provide Business Update on Thursday, April 30, 2026
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom (PHAT) Q4 2025 Earnings Call Transcript ↗
    Via The Motley Fool
    Topics Earnings
    News headline image
    Phathom Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Financial Guidance
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals to Participate in Upcoming Investor Conferences
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on Thursday, February 26, 2026
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharmaceuticals to Present at the Guggenheim Emerging Outlook Biotech Summit 2026
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    News headline image
    Phathom Pharma Shows Sales Strength, Targets 2026 Profitability ↗
    Via Benzinga
    Get insights into the top gainers and losers of Thursday's pre-market session. ↗
    Via Chartmill
    News headline image
    Phathom Pharmaceuticals Announces Pricing of $130 Million Public Offering of Common Stock and Pre-Funded Warrants
    From Phathom Pharmaceuticals
    Via GlobeNewswire
    Stay updated with the stocks that are on the move in today's after-hours session. ↗
    Via Chartmill
    News headline image
    Phathom Pharmaceuticals Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants
    From Phathom Pharmaceuticals
    Via GlobeNewswire

    Frequently Asked Questions

    Is Phathom Pharmaceuticals, Inc. - Common Stock publicly traded?
    Yes, Phathom Pharmaceuticals, Inc. - Common Stock is publicly traded.
    What exchange does Phathom Pharmaceuticals, Inc. - Common Stock trade on?
    Phathom Pharmaceuticals, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Phathom Pharmaceuticals, Inc. - Common Stock?
    The ticker symbol for Phathom Pharmaceuticals, Inc. - Common Stock is PHAT on the Nasdaq Stock Market
    What is the current price of Phathom Pharmaceuticals, Inc. - Common Stock?
    The current price of Phathom Pharmaceuticals, Inc. - Common Stock is 8.785
    When was Phathom Pharmaceuticals, Inc. - Common Stock last traded?
    The last trade of Phathom Pharmaceuticals, Inc. - Common Stock was at 08/26/26 10:56 AM ET
    What is the market capitalization of Phathom Pharmaceuticals, Inc. - Common Stock?
    The market capitalization of Phathom Pharmaceuticals, Inc. - Common Stock is 383.15M
    How many shares of Phathom Pharmaceuticals, Inc. - Common Stock are outstanding?
    Phathom Pharmaceuticals, Inc. - Common Stock has 383M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.